CEO Donghyun Park Increases Stake via Open Market Purchases but Ownership Dips to 6.05% Due to Share Count Rise

Mezzion Pharma CEO Donghyun Park acquired an additional 1,231 common shares through open market purchases on July 21, 2026, increasing his total holdings to 1,852,214 shares.
Purchase prices ranged from 50,100 KRW to 50,900 KRW per share, with an average acquisition cost of 50,229 KRW.
However, total outstanding shares increased from 30,392,167 to 30,605,994 shares since the last report, causing his ownership percentage to edge down from 6.09% to 6.05%.
CEO Park is a registered executive and de facto controlling shareholder; this purchase may signal management confidence in the company.
[AI Summary]CEO insider buying provides a positive signal, but the dilution from increased share count neutralizes the effect, resulting in a neutral fundamental impact. No additional capital allocation plans or share buyback programs have been disclosed, suggesting limited near-term price catalysts.